Skip to content

Latest

Half of Frito-Lay product lineup to be all-natural

Frito-Lay North America plans to make about 50% of its product portfolio with all-natural ingredients and has begun shipping the first natural snacks to retailers. The PepsiCo division said Tuesday that the strategy includes three of its biggest brands: Lay’s, Tostitos and SunChips.

Consumer confidence dips in December

Though drug store chains and other retailers got a lift from a late-season holiday sales surge, consumer confidence waned in December, according to a major economic benchmark.

Rite Aid kicks off Resolutions Rewards

Rite Aid Corp.’s wellness+ customer loyalty card is the centerpiece of a New Year-themed sweepstakes program that runs through late next month. The drug store chain said Tuesday that customers who use their wellness+ card from now through Jan.

BioScrip wraps up debt refinancing

BioScrip Inc. has closed a new $150 million syndicated revolving credit facility. The pharmacy services company said Tuesday that the new facility will be structured as an amendment and restatement of the prior $100 million term loan and $50 million revolver.

Coty readies flurry of Sally Hansen launches

Coty Inc. is launching a wide range of Sally Hansen beauty implements and nail care products in the first quarter, including polish, polish strips, gel treatments and growth serum. The company is also rolling out new Sally Hansen hand creams, foot care products, lip treatments and a depilatory.

Sustainability strategy progresses at Nice-Pak

Nice-Pak Products Inc. has transformed its Mooresville, Ind., manufacturing plant into what it calls a “zero landfill” facility. The move, expected to keep more than 4,200 tons of waste a year from going into landfills, is the second transformation of a Nice-Pak facility in the past six months.

Cephalon names Buchi as CEO

Cephalon Inc. has appointed J. Kevin Buchi as chief executive officer and a member of the biopharmaceutical company’s board. The move comes following the death of Cephalon founder, chairman and CEO Frank Baldino Jr. earlier this month at age 57 from complications related to leukemia.

PhRMA elects new board members

The Pharmaceutical Research and Manufacturers of America (PhRMA) this week announced the election of four new members to its board of directors. PhRMA said Tuesday that the new board members are Ian Read, president and chief executive officer of Pfizer Inc.; Jerzy Gruhn, president Novo Nordisk Inc.